Literature DB >> 20924776

Simultaneous expansion and harvest of hematopoietic stem cells and mesenchymal stem cells derived from umbilical cord blood.

Song Kedong1, Fan Xiubo, Liu Tianqing, Hugo M Macedo, Jiang LiLi, Fang Meiyun, Shi Fangxin, Ma Xuehu, Cui Zhanfeng.   

Abstract

The simultaneous expansion and harvest of hematopoietic stem cells and mesenchymal stem cells derived from umbilical cord blood were carried out using bioreactors. The co-culture of umbilical cord blood (UCB)-derived hematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs) was performed within spinner flasks and a rotating wall vessel (RWV) bioreactor using glass-coated styrene copolymer (GCSC) microcarriers. The medium used was composed of serum-free IMDM containing a cocktail of SCF 15 ng·mL(-1), FL 5 ng·mL(-1), TPO 6 ng·mL(-1), IL-3 15 ng·mL(-1), G-CSF 1 ng·mL(-1) and GM-CSF 5 ng·mL(-1). Accessory stromal cells derived from normal allogeneic adipose tissue were encapsulated in alginate-chitosan (AC) beads and used as feeding cells. The quality of the harvested UCB-HSCs and MSCs was assessed by immunophenotype analysis, methylcellulose colony and multi-lineage differentiation assays. After 12 days of culture, the fold-expansion of total cell numbers, colony-forming units (CFU-C), CD34(+)/CD45(+)/CD105(-) (HSCs) cells and CD34(-)/CD45(-)/CD105(+) (MSCs) cells using the RWV bioreactor were (3.7 ± 0.3)- , (5.1 ± 1.2)- , (5.2 ± 0.4)- , and (13.9 ± 1.2)-fold respectively, significantly better than those obtained using spinner flasks. Moreover, UCB-HSCs and UCB-MSCs could be easily separated by gravity sedimentation after the co-culture period as only UCB-MSCs adhered on to the microcarriers. Simultaneously, we found that the fibroblast-like cells growing on the surface of the GCSC microcarriers could be induced and differentiated towards the osteoblastic, chondrocytic and adipocytic lineages. Phenotypically, these cells were very similarly to the MSCs derived from bone marrow positively expressing the MSCs-related markers CD13, CD44, CD73 and CD105, while negatively expressing the HSCs-related markers CD34, CD45 and HLA-DR. It was thus demonstrated that the simultaneous expansion and harvest of UCB-HSCs and UCB-MSCs is possible to be accomplished using a feasible bioreactor culture system such as the RWV bioreactor with the support of GCSC microcarriers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20924776     DOI: 10.1007/s10856-010-4167-5

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  28 in total

Review 1.  Mesenchymal stem cells: biology and potential clinical uses.

Authors:  R J Deans; A B Moseley
Journal:  Exp Hematol       Date:  2000-08       Impact factor: 3.084

Review 2.  Haemopoietic stem cells.

Authors:  Ilaria Bellantuono
Journal:  Int J Biochem Cell Biol       Date:  2004-04       Impact factor: 5.085

3.  Ex vivo expansion of hematopoietic stem cells derived from umbilical cord blood in rotating wall vessel.

Authors:  Yang Liu; Tianqing Liu; Xiubo Fan; Xuehu Ma; Zhanfeng Cui
Journal:  J Biotechnol       Date:  2006-03-02       Impact factor: 3.307

4.  Effective expansion of umbilical cord blood hematopoietic stem/progenitor cells by regulation of microencapsulated osteoblasts under hypoxic condition.

Authors:  Kedong Song; Guofeng Zhao; Tianqing Liu; Lei Zhang; Xuehu Ma; Jing Liu; Zhanfeng Cui
Journal:  Biotechnol Lett       Date:  2009-03-08       Impact factor: 2.461

5.  Comparison of mesenchymal stem cells derived from arterial, venous, and Wharton's jelly explants of human umbilical cord.

Authors:  Ikuo Ishige; Tokiko Nagamura-Inoue; Masaki J Honda; Ratanakanit Harnprasopwat; Michiko Kido; Mitsuhiro Sugimoto; Hiromitsu Nakauchi; Arinobu Tojo
Journal:  Int J Hematol       Date:  2009-08-06       Impact factor: 2.490

6.  Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.

Authors:  M J Laughlin; J Barker; B Bambach; O N Koc; D A Rizzieri; J E Wagner; S L Gerson; H M Lazarus; M Cairo; C E Stevens; P Rubinstein; J Kurtzberg
Journal:  N Engl J Med       Date:  2001-06-14       Impact factor: 91.245

7.  Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood.

Authors:  Wolfgang Wagner; Frederik Wein; Anja Seckinger; Maria Frankhauser; Ute Wirkner; Ulf Krause; Jonathon Blake; Christian Schwager; Volker Eckstein; Wilhelm Ansorge; Anthony D Ho
Journal:  Exp Hematol       Date:  2005-11       Impact factor: 3.084

8.  Homing of in vitro expanded Stro-1- or Stro-1+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment.

Authors:  Morad Bensidhoum; Alain Chapel; Sabine Francois; Christelle Demarquay; Christelle Mazurier; Loic Fouillard; Sandrine Bouchet; Jean Marc Bertho; Patrick Gourmelon; Jocelyne Aigueperse; Pierre Charbord; Norbert Claude Gorin; Dominique Thierry; Manuel Lopez
Journal:  Blood       Date:  2004-01-08       Impact factor: 22.113

9.  Large generation of megakaryocytes from serum-free expanded human CD34+ cells.

Authors:  Te-Wei Chen; Chao-Ling Yao; I-Ming Chu; Tzu-Lin Chuang; Tzu-Bou Hsieh; Shiaw-Min Hwang
Journal:  Biochem Biophys Res Commun       Date:  2008-11-21       Impact factor: 3.575

10.  Effect of Subcultivation of Human Bone Marrow Mesenchymal Stem on their Capacities for Chondrogenesis, Supporting Hematopoiesis, and Telomea Length.

Authors:  Masaki Nakahara; Mutsumi Takagi; Takako Hattori; Shigeyuki Wakitani; Toshiomi Yoshida
Journal:  Cytotechnology       Date:  2005-01       Impact factor: 2.058

View more
  5 in total

1.  Pilot social feasibility study for the establishment of a public human umbilical cord blood stem cell bank in South Africa.

Authors:  Madelein Meissner-Roloff; Wendy Young; Isabella Rangaka; Hennie Lombaard; Ames Dhai; Norma Tsotsi; Michael S Pepper
Journal:  Stem Cell Rev Rep       Date:  2012-12       Impact factor: 5.739

Review 2.  Hematopoietic stem cells: multiparameter regulation.

Authors:  Kedong Song; Liying Li; Yiwei Wang; Tianqing Liu
Journal:  Hum Cell       Date:  2016-02-16       Impact factor: 4.174

3.  RCCS enhances EOE cell proliferation and their differentiation into ameloblasts.

Authors:  Ping Li; Ye Zhang; Yan Meng Wang; Cui Mi Duan; Tong Hao; Bu Ling Wu; Chang Yong Wang
Journal:  Mol Biol Rep       Date:  2011-06-11       Impact factor: 2.316

4.  Manufacturing mesenchymal stromal cells for phase I clinical trials.

Authors:  Patrick J Hanley; Zhuyong Mei; Maria da Graca Cabreira-Hansen; Mariola Klis; Wei Li; Yali Zhao; April G Durett; Xingwu Zheng; Yongping Wang; Adrian P Gee; Edwin M Horwitz
Journal:  Cytotherapy       Date:  2013-04       Impact factor: 5.414

5.  Large scale expansion of human umbilical cord cells in a rotating bed system bioreactor for cardiovascular tissue engineering applications.

Authors:  Anne Reichardt; Bianca Polchow; Mehdi Shakibaei; Wolfgang Henrich; Roland Hetzer; Cora Lueders
Journal:  Open Biomed Eng J       Date:  2013-06-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.